The GSK share price has had a rotten few years and now it's heading south yet again. Investor Harvey Jones continues to hang ...
On Friday, the Federal Trade Commission (FTC) filed a formal complaint against three major pharmacy benefit managers ...
FluMist is the only flu vaccine administered by nasal spray, not injection. It is licensed for individuals between the ages ...
The U.S. Food and Drug Administration said on Friday it has approved AstraZeneca's influenza nasal spray vaccine for ...
Zacks.com on MSN2d
Pharma Stock Roundup: FDA Approvals for LLY, MRK, AZN & JNJ DrugsThis week, the FDA approved Eli Lilly’s LLY eczema drug, Ebglyss (lebrikizumab), and the expanded use of Novartis’ NVS ...
Americans love their Star-Spangled Banner, the French are obsessed with national pride but we Brits have a patriotism problem ...
In the first half of 2024, AstraZeneca reported sales that grew more than 10% year over year for 21 different drugs. With ...
According to Biospace.com "The solid tumors market size reached a value of US$ 170.3 Billion in 2023. Looking forward, the market is expected to reach US$ 375.4 Billion by 2034, exhibiting a growth ...
We recently published a list of 10 Best Big-Name Stocks to Buy Right ... selling on individual US-listed stocks […] A Phase 3 ...
Aronne, MD, of Weill Cornell Medicine in New York City, made a compelling case that the next generation of obesity ...
AstraZeneca is continuing to study AZD8205 as a monotherapy in dose optimization expansion cohorts of patients with ...
Two of the simplest ways to measure the success of companies that develop and commercialize drugs is to count their approvals ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback